Liquid Biopsy Testing Can Improve Selection of Advanced Non-Small-Cell Lung Cancer Patients to Rechallenge with Gefitinib

The ICARUS trial is a phase II, open label, multicenter, single arm study conducted to investigate the efficacy, safety, and tolerability of a rechallenge treatment with the first-generation tyrosine kinase inhibitor (TKI) gefitinib in advanced non-small-cell lung cancer (NSCLC) patients carrying ac...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancers (Basel)
Autores principales: Esposito Abate, Riziero, Pasquale, Raffaella, Sacco, Alessandra, Piccirillo, Maria Carmela, Morabito, Alessandro, Bidoli, Paolo, Finocchiaro, Giovanna, Chiari, Rita, Foltran, Luisa, Buosi, Roberta, Tiseo, Marcello, Giannetta, Laura, Battiloro, Ciro, Fasola, Gianpiero, Romano, Gianpiero, Ciuffreda, Libero, Frassoldati, Antonio, de Marinis, Filippo, Cappuzzo, Federico, Normanno, Nicola
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6826724/
https://ncbi.nlm.nih.gov/pubmed/31557965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11101431
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares